In HCC, miR-21 inhibited the expression of the p53 activator HBP1, diminishing the p53 tumor suppression activity, and augmenting the expression of SREBP1c which promoted lipid accumulation and hepatic tumorigenesis [57]. The gene discussed is SREBF1; the disease is neoplasm.